Study: New Heart Pill Beats Plavix

Nov 04, 2007 By MARILYNN MARCHIONE, AP Medical Writer
Study: New Heart Pill Beats Plavix (AP)
Dr. Steven Nissen poses in his lab at the Cleveland Clinic beside screens with images of coronary arteries as seen by intravascular ultrasound in Cleveland, Ohio, Jan. 16, 2004. The experimental drug, prasugrel, a new blood thinner proved better than Plavix, one of the world's top-selling drugs, at preventing heart problems after procedures to open clogged arteries, doctors reported Sunday Nov. 4, 2007. But the new drug also raised the risk of serious bleeding. "I'm encouraged by the results" and think prasugrel should win Food and Drug Administration approval because it so dramatically cuts non-fatal heart attacks, said the Cleveland Clinic's Dr. Steven Nissen, a frequent government adviser. (AP Photo/Amy Sancetta)

(AP) -- A new blood thinner proved better than Plavix, one of the world's top-selling drugs, at preventing heart problems after procedures to open clogged arteries, doctors reported Sunday. But the new drug also raised the risk of serious bleeding.



Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .

Explore further: FDA investigates deaths of patients on antipsychotic drug

add to favorites email to friend print save as pdf

Related Stories

WWF urges Romania, Bulgaria to protect wild sturgeon

52 minutes ago

Conservationist group WWF on Tuesday urged Romania and Bulgaria, home to the last viable wild sturgeon populations in the European Union, to protect the species, threatened by illegal fishing and caviar trade.

Mathematical algorithms cut train delays

1 hour ago

Commuters are already seeing a reduction in delays and waiting times thanks to new software able to adapt railway schedules in real time following unforeseen disruptions.

The dissector and the draughtsman

1 hour ago

Between 1831 and 1854, the French anatomist Jean-Marc Bourgery and his compatriot Nicolas-Henri Jacob, a versatile artist, produced a richly illustrated and ground-breaking medical textbook. The "Traité ...

Recommended for you

Protalix signs supply deal with Brazilian govt

18 hours ago

Shares of Protalix BioTherapeutics Inc. jumped in premarket trading Wednesday after the drug developer announced a deal that requires the Brazilian government to buy at least $280 million of the company's Gaucher disease ...

EU fines pharma firms over generics delay (Update)

18 hours ago

(AP)—The European Union has fined Danish pharmaceuticals multinational Lundbeck and several other producers a combined 146 million euros ($195 million) for delaying the market entry of cheaper generic alternatives ...

Investigational drug improves sleep disorder among the blind

Jun 17, 2013

An investigational new drug significantly improved a common and debilitating circadian rhythm sleep disorder that frequently affects people who are completely blind, a multicenter study finds. The results were presented Monday ...

User comments : 0

More news stories

LA to give every student an iPad; $30M order

Los Angeles' school system, the second largest in the United States, is ordering iPads for all its students, handing Apple a major success in its quest to make the tablet computer a replacement for textbooks.